S.N 16 -Kelun Pharmaceutical Group
New construction and renovation projects
Project location: All over the country
Equipment selection: dozens of sets of 465KW~~6978KW steam-fired, hot water LiBr Absorption Chiller
Main function: Industrial cooling of production line
Energy Conservation: Annual electricity savings amount to approximately 64 million kWh, equivalent to reducing standard coal consumption by about 7,870 tons.
Return on Investment: Annual electricity cost savings amount to approximately 44.8 million CNY (calculated at an average electricity rate of 0.7 CNY/kWh); Annual maintenance costs are reduced by approximately 35% compared to traditional electric chiller.
General introduction
Kelun Pharmaceutical Group is a highly specialized and innovative pharmaceutical conglomerate with annual sales revenue exceeding 40 billion yuan. The group includes several subsidiaries, such as:
- Sichuan Kelun Pharmaceutical Co., Ltd.
- Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.
- Klus Pharma Inc. (based in the United States)
- Kelun KAZ Pharmaceutical Co., Ltd. (based in Kazakhstan)
- Sichuan Kelun Pharmaceutical Trading Co., Ltd.
In 2017, Kelun ranked 155th among China's Top 500 Manufacturing Industries, and it holds one of the top three positions in China's pharmaceutical industry in terms of overall strength. In 2018, Kelun was recognized as a demonstration enterprise in the manufacturing industry, thanks to its global leadership in the production of large-capacity injections.
Kelun's focus on innovation, research and development, and global expansion has solidified its position as a prominent player in the pharmaceutical sector both domestically and internationally.
Web: https://www.deepbluechiller.com/
E-Mail: yut@dlhope.com / young@dlhope.com
Mob: +86 15882434819/+86 15680009866
Post time: Mar-30-2023
